Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$85.37 - $115.44 $35,087 - $47,445
-411 Reduced 10.27%
3,592 $382,000
Q4 2023

Jan 24, 2024

BUY
$69.51 - $104.43 $67,980 - $102,132
978 Added 32.33%
4,003 $398,000
Q3 2023

Oct 24, 2023

BUY
$96.41 - $126.61 $291,640 - $382,995
3,025 New
3,025 $312,000
Q3 2021

Oct 19, 2021

SELL
$221.9 - $484.47 $210,361 - $459,277
-948 Closed
0 $0
Q2 2021

Jul 19, 2021

BUY
$129.91 - $234.98 $123,154 - $222,761
948 New
948 $223,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Stratos Wealth Advisors, LLC Portfolio

Follow Stratos Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.